Israel Can Not Compete With "Cannabis Manufacturers in the U.S."
Co-Chair of the firm's Israel Practice Meital Stavinsky sat down with Calcalist to discuss how the State of Israel would not be able compete with U.S. manufacturers if cannabis was legalized federally. Ms. Stavinsky was accompanied by the Department of Agriculture's Commissioner Nikki Fried, who discussed that if federal legalization were to occur then drug companies would step in and purchase cannabis companies to guarantee that medical cannabis patients would receive full insurance coverage. However, for more doctors and the FDA to get on board, then more research need to be done on cannabis. This is where the State of Israel would see activity in the market.
"The concerns raised in the FDA public debate regarding the lack of clinical information about the CBD in the U.S. are well established. This is exactly where the State of Israel is connected, which has been able to support research and development in the field of medical cannabis for decades," stated Ms. Stavinsky.
READ: Israel Can Not Compete With "Cannabis Manufacturers in the U.S." (This article is in Hebrew)